This bulletin covers aspects of head and neck cancers and should be of interest to multidisciplinary teams working in this area.

Sections can include: Combined Modality Therapies Drug Therapy Pathology, Staging, Polymorphisms & Biomarkers Prognosis, Survival & Risk Factors Radiotherapy & Imaging Supportive Care & Symptom Management Surgery

Many of the following articles are available online via the NHS Scotland Knowledge Network. Please use the links where provided and your ATHENS password. A complete list of available online journals and registration for ATHENS can be found at www.knowledge.scot.nhs.uk/

If the article you require is not available via the NHS Scotland Knowledge Network and you would like to request a print copy, please submit your request online at www.quest.scot.nhs.uk

This bulletin contains a selection of material gathered from a search of the evidence base, and is not intended to be comprehensive. Professional judgment should be exercised when appraising the material. The Library takes no responsibility for the wording, content and accuracy of the information supplied, which has been extracted in good faith from reputable sources. NHSGGC is not responsible for the content of external internet sites.

Compiled by:Kirsty ColtartSubject LibrarianBeatson West of Scotland Cancer Centre0141 301 7285, kirsty.coltart@ggc.scot.nhs.uk

General

Head and Neck Cancer, May 2016Kirsty Coltart, Subject Librarian, NHSGGC Library Network

1

Head and Neck CancerMay 2016

Bark, R., Mercke, C., Munck-Wikland, E., et al. (2016). Cancer of the gingiva. European Archives of Oto-Rhino-Laryngology 273,6:1335-1345.

Chua, M.L.K., Wee, J.T.S., Hui, E.P., et al. (2016). Nasopharyngeal carcinoma. Lancet 387,10022:1012-1024.

Deep, N.L., Ekbom, D.C., Hinni, M.L., et al. (2016). High-Grade Neuroendocrine Carcinoma of the Larynx: The Mayo Clinic Experience. Annals of Otology, Rhinology & Laryngology 125,6:464-469.

Edson, M.A., Garden, A.S., Takiar, V., et al. (2016). Outcomes for hypopharyngeal carcinoma treated with organ-preservation therapy. Head & neck 38,Suppl 1:E2091-9.

Glazer, T.A. and Shuman, A.G. (2016). Distant Metastases and Palliative Care. Advances in Oto-Rhino-Laryngology 78,182-188.

Johnston, M.L., Huang, S.H., Waldron, J.N., et al. (2016). Salivary duct carcinoma: Treatment, outcomes, and patterns of failure. Head & neck 38,Suppl 1:E820-6.

Karatayli-Ozgursoy, S., Bishop, J.A., Hillel, A.T., et al. (2016). Non-epithelial tumors of the larynx: a single institution review. American Journal of Otolaryngology 37,3:279-285.

Kiess, A.P. and Quon, H. (2016). Management of Inoperable Malignant Neoplasms. Advances in Oto-Rhino-Laryngology 78,157-167.

Lewis, A.G., Tong, T. and Maghami, E. (2016). Diagnosis and Management of Malignant Salivary Gland Tumors of the Parotid Gland. Otolaryngologic clinics of North America 49,2:343-380.

Marur, S. and Forastiere, A.A. (2016). Head and Neck Squamous Cell Carcinoma: Update on Epidemiology, Diagnosis, and Treatment. Mayo Clinic proceedings 91,3:386-396.

Pagh, A., Grau, C. and Overgaard, J. (2016). Failure pattern and salvage treatment after radical treatment of head and neck cancer. Acta Oncologica 55,5:625-632.

Combined Modality Therapies

Bussu, F., Mura, F., Micciche, F., et al. (2016). Oncologic outcome of hypopharyngeal carcinoma treated with different modalities at 2 different university hospitals. Head & neck 38,4:606-612.

Fury, M.G., Xiao, H., Sherman, E.J., et al. (2016). Phase II trial of bevacizumab+cetuximab+cisplatin with concurrent intensity-modulated radiation therapy for patients with stage III/IVB head and neck squamous cell carcinoma. Head & neck 38,Suppl 1:E566-70.

Gorayski, P., Foote, M., Porceddu, S., et al. (2016). The Role of Postoperative Radiotherapy for Large Nerve Perineural Spread of Cancer of the Head and Neck. Journal of Neurological Surgery Part B Skull Base 77,2:173-181.

Heukelom, J., Lopez-Yurda, M., Balm, A.J.M., et al. (2016). Late follow-up of the randomized radiation and concomitant high-dose intra-arterial or intravenous cisplatin (RADPLAT) trial for advanced head and neck cancer. Head & neck 38,Suppl 1:E488-93.

Head and Neck Cancer, May 2016Kirsty Coltart, Subject Librarian, NHSGGC Library Network

2

Hutcheson, K.A., Abualsamh, A.R., Sosa, A., et al. (2016). Impact of selective neck dissection on chronic dysphagia after chemo-intensity-modulated radiotherapy for oropharyngeal carcinoma. Head & neck 38,6:886-893.

Lee, J.Y., Sun, J., Oh, D.R., et al. (2016). Comparison of weekly versus triweekly cisplatin delivered concurrently with radiation therapy in patients with locally advanced nasopharyngeal cancer: A multicenter randomized phase II trial (KCSG-HN10-02). Radiotherapy & Oncology 118,2:244-250.

Lorch, J.H., Hanna, G.J., Posner, M.R., et al. (2016). Human papillomavirus and induction chemotherapy versus concurrent chemoradiotherapy in locally advanced oropharyngeal cancer: The Dana Farber Experience. Head & neck 38,Suppl 1:E1618-24.

Nien, H., Sturgis, E.M., Kies, M.S., et al. (2016). Comparison of systemic therapies used concurrently with radiation for the treatment of human papillomavirus-associated oropharyngeal cancer. Head & neck 38,Suppl 1:E1554-61.

Paderno, A., Piazza, C., Bresciani, L., et al. (2016). Microvascular head and neck reconstruction after (chemo)radiation: facts and prejudices. Current Opinion in Otolaryngology & Head & Neck Surgery 24,2:83-90.

Rosenthal, D.I., Harari, P.M., Giralt, J., et al. (2016). Association of Human Papillomavirus and p16 Status With Outcomes in the IMCL-9815 Phase III Registration Trial for Patients With Locoregionally Advanced Oropharyngeal Squamous Cell Carcinoma of the Head and Neck Treated With Radiotherapy With or Without Cetuximab. Journal of Clinical Oncology 34,12:1300-1308.

Strojan, P., Vermorken, J.B., Beitler, J.J., et al. (2016). Cumulative cisplatin dose in concurrent chemoradiotherapy for head and neck cancer: A systematic review. Head & neck 38,Suppl 1:E2151-8.

Drug & Targeted Therapies

Janoray, G., Pointreau, Y., Garaud, P., et al. (2016). Long-term Results of a Multicenter Randomized Phase III Trial of Induction Chemotherapy With Cisplatin, 5-fluorouracil, +/- Docetaxel for Larynx Preservation. Journal of the National Cancer Institute 108,4:

Mockelmann, N., Kriegs, M., Lorincz, B.B., et al. (2016). Molecular targeting in combination with platinum-based chemoradiotherapy in head and neck cancer treatment. Head & neck 38,Suppl 1:E2173-81.

Msaouel, P. and Massarelli, E. (2016). Immune Checkpoint Therapy in Head and Neck Cancers. Cancer Journal 22,2:108-116.

Rischin, D., Spigel, D.R., Adkins, D., et al. (2016). PRISM: Phase 2 trial with panitumumab monotherapy as second-line treatment in patients with recurrent or metastatic squamous cell carcinoma of the head and neck. Head & neck 38,Suppl 1:E1756-61.

Szturz, P., Specenier, P., Van Laer, C., et al. (2016). Long-term remission of locally recurrent oropharyngeal cancer after docetaxel-based chemotherapy plus cetuximab. European Archives of Oto-Rhino-Laryngology 273,6:1629-1636.

Pathology, Staging, Polymorphisms & Biomarkers

Head and Neck Cancer, May 2016Kirsty Coltart, Subject Librarian, NHSGGC Library Network

3

Amit, M., Eran, A., Billan, S., et al. (2016). Perineural Spread in Noncutaneous Head and Neck Cancer: New Insights into an Old Problem. Journal of Neurological Surgery Part B Skull Base 77,2:86-95.

Bishop, J.A. (2016). Recently described neoplasms of the sinonasal tract. Seminars in diagnostic pathology 33,2:62-70.

Daniele, L., Nikolarakos, D., Keenan, J., et al. (2016). Clear cell carcinoma, not otherwise specified/hyalinising clear cell carcinoma of the salivary gland: The current nomenclature, clinical/pathological characteristics and management. Critical Reviews in Oncology-Hematology 102,55-64.

Fives, C., Feeley, L., O'Leary, G., et al. (2016). Importance of lymphovascular invasion and invasive front on survival in floor of mouth cancer. Head & neck 38,Suppl 1:E1528-34.

Ha, P.K. and Stenman, G. (2016). Molecular Pathology and Biomarkers. Advances in Oto-Rhino-Laryngology 78,17-24.

Haderlein, M., Scherl, C., Semrau, S., et al. (2016). High-grade histology as predictor of early distant metastases and decreased disease-free survival in salivary gland cancer irrespective of tumor subtype. Head & neck 38,Suppl 1:E2041-8.

Marques, A.E.M., Elias, S.T., Porporatti, A.L., et al. (2016). mTOR pathway protein immunoexpression as a prognostic factor for survival in head and neck cancer patients: a systematic review and meta-analysis. Journal of Oral Pathology & Medicine 45,5:319-328.

Matsumoto, F., Ohba, S., Fujimaki, M., et al. (2016). The value of insulin-like growth factor-1 receptor for predicting early glottic carcinoma response to radiotherapy. Auris, Nasus, Larynx 43,4:440-445.

Roberts, T.J., Colevas, A.D., Hara, W., et al. (2016). Number of positive nodes is superior to the lymph node ratio and American Joint Committee on Cancer N staging for the prognosis of surgically treated head and neck squamous cell carcinomas. Cancer 122,9:1388-1397.

Seoane, J., Alvarez-Novoa, P., Gomez, I., et al. (2016). Early oral cancer diagnosis: The Aarhus statement perspective. A systematic review and meta-analysis. Head & neck 38,Suppl 1:E2182-9.

Simons, S.A., Bridge, J.A. and Leon, M.E. (2016). Sinonasal small round blue cell tumors: An approach to diagnosis. Seminars in diagnostic pathology 33,2:91-103.

Prognosis, Survival & Risk Factors

Cohen, E.E.W., LaMonte, S.J., Erb, N.L., et al. (2016). American Cancer Society Head and Neck Cancer Survivorship Care Guideline. CA: a Cancer Journal for Clinicians 66,3:203-239.

Farnebo, L., Malila, N., Makitie, A., et al. (2016). Early death among head and neck cancer patients. Current Opinion in Otolaryngology & Head & Neck Surgery 24,2:115-120.

Gooi, Z., Chan, J.Y.K. and Fakhry, C. (2016). The epidemiology of the human papillomavirus related to oropharyngeal head and neck cancer. Laryngoscope 126,4:894-900.

Head and Neck Cancer, May 2016Kirsty Coltart, Subject Librarian, NHSGGC Library Network

4

Kjaer, T.K., Johansen, C., Andersen, E., et al. (2016). Influence of social factors on patient-reported late symptoms: Report from a controlled trial among long-term head and neck cancer survivors in Denmark. Head & neck 38,Suppl 1:E1713-21.

Kjaer, T., Johansen, C., Andersen, E., et al. (2016). Do we reach the patients with the most problems? Baseline data from the WebCan study among survivors of head-and-neck cancer, Denmark. Journal of Cancer Survivorship 10,2:251-260.

Kutler, D.I., Patel, K.R., Auerbach, A.D., et al. (2016). Natural history and management of Fanconi anemia patients with head and neck cancer: A 10-year follow-up. Laryngoscope 126,4:870-879.

Schwam, Z.G., Sosa, J.A., Roman, S., et al. (2016). Receipt of Care Discordant with Practice Guidelines is Associated with Compromised Overall Survival in Nasopharyngeal Carcinoma. Clinical Oncology (Royal College of Radiologists) 28,6:402-409.

Zhou, J., Zhang, D., Yang, Y., et al. (2016). Association between helicobacter pylori infection and carcinoma of the larynx or pharynx. Head & neck 38,Suppl 1:E2291-6.

Radiotherapy & Imaging

Chung, C., Lo, W., Lee, Y., et al. (2016). Image-enhanced endoscopy for detection of second primary neoplasm in patients with esophageal and head and neck cancer: A systematic review and meta-analysis. Head & neck 38,Suppl 1:E2343-9.

Co, J., Mejia, M.B. and Dizon, J.M. (2016). Evidence on effectiveness of intensity-modulated radiotherapy versus 2-dimensional radiotherapy in the treatment of nasopharyngeal carcinoma: Meta-analysis and a systematic review of the literature. Head & neck 38,Suppl 1:E2130-42.

Cote, M., Trudel, M., Wang, C., et al. (2016). Improving Quality of Life With Nabilone During Radiotherapy Treatments for Head and Neck Cancers: A Randomized Double-Blind Placebo-Controlled Trial. Annals of Otology, Rhinology & Laryngology 125,4:317-324.

Cuaron, J., Rao, S., Wolden, S., et al. (2016). Patterns of failure in patients with head and neck carcinoma of unknown primary treated with radiation therapy. Head & neck 38,Suppl 1:E426-31.

Davis, C., Sikes, J., Namaranian, P., et al. (2016). Neutron Beam Radiation Therapy: An Overview of Treatment and Oral Complications When Treating Salivary Gland Malignancies. Journal of Oral & Maxillofacial Surgery 74,4:830-835.

de Bree, R., van der Putten, L., van Tinteren, H., et al. (2016). Effectiveness of an (18)F-FDG-PET based strategy to optimize the diagnostic trajectory of suspected recurrent laryngeal carcinoma after radiotherapy: The RELAPS multicenter randomized trial. Radiotherapy & Oncology 118,2:251-256.

Fortin, B., Khaouam, N., Filion, E., et al. (2016). Palliative Radiation Therapy for Advanced Head and Neck Carcinomas: A Phase 2 Study. International journal of radiation oncology, biology, physics 95,2:647-653.

Garg, S., Kilburn, J.M., Lucas, J.T.J., et al. (2016). Reirradiation for second primary or recurrent cancers of the head and neck: Dosimetric and outcome analysis. Head & neck 38,Suppl 1:E961-9.

Gutiontov, S.I., Shin, E.J., Lok, B., et al. (2016). Intensity-modulated radiotherapy for head and neck surgeons. Head & neck 38,Suppl 1:E2368-73.

Head and Neck Cancer, May 2016Kirsty Coltart, Subject Librarian, NHSGGC Library Network

5

Henriques de Figueiredo, B. and Gregoire, V. (2016). How to minimize morbidity in radiotherapy of pharyngolaryngeal tumors?. Current Opinion in Otolaryngology & Head & Neck Surgery 24,2:163-169.

Karam, I., Huang, S.H., McNiven, A., et al. (2016). Outcomes after reirradiation for recurrent nasopharyngeal carcinoma: North American experience. Head & neck 38,Suppl 1:E1102-9.

Katsoulakis, E., Riaz, N., Hu, M., et al. (2016). Hypopharyngeal squamous cell carcinoma: Three-dimensional or Intensity-modulated radiotherapy? A single institution's experience. Laryngoscope 126,3:620-626.

Ku, Y., Wong, Y., Fu, C., et al. (2016). Timely Antecedent CT or MRI Can Help Predict Hemorrhage Site of Posttreatment Head and Neck Cancer, With Digital Subtraction Angiography Used as the Reference Standard. AJR.American Journal of Roentgenology 206,4:829-836.

Lee, S., Kang, K.W. and Wu, H. (2016). Prospective investigation and literature review of tolerance dose on salivary glands using quantitative salivary gland scintigraphy in the intensity-modulated radiotherapy era. Head & neck 38,Suppl 1:E1746-55.

Li, C., Zhang, C., Li, N., et al. (2016). Compression Real-time Elastography for Evaluation of Salivary Gland Lesions: A Meta-analysis. Journal of Ultrasound in Medicine 35,5:999-1007.

Mehanna, H., Wong, W., McConkey, C.C., et al. (2016). PET-CT Surveillance versus Neck Dissection in Advanced Head and Neck Cancer. New England Journal of Medicine 374,15:1444-1454.

Min, M., Lin, P., Lee, M., et al. (2016). Prognostic Value of 2-[(18)F] Fluoro-2-deoxy-D-glucose Positron Emission Tomography-Computed Tomography Scan Carried out During and After Radiation Therapy for Head and Neck Cancer Using Visual Therapy Response Interpretation Criteria. Clinical Oncology (Royal College of Radiologists) 28,6:393-401.

Nyqvist, J., Fransson, P., Laurell, G., et al. (2016). Differences in health related quality of life in the randomised ARTSCAN study; accelerated vs. conventional radiotherapy for head and neck cancer. A five year follow up. Radiotherapy & Oncology 118,2:335-341.

Saade, C., El-Merhi, F., Mayat, A., et al. (2016). Comparison of Standard and Quadruple-Phase Contrast Material Injection for Artifacts, Image Quality, and Radiation Dose in the Evaluation of Head and Neck Cancer Metastases. Radiology 279,2:571-577.

Seol, K.H. and Lee, J.E. (2016). Patterns of failure after the reduced volume approach for elective nodal irradiation in nasopharyngeal carcinoma. Radiation Oncology Journal 34,1:10-17.

Shaw, S.M., Skoretz, S.A., O'Sullivan, B., et al. (2016). Valid and reliable techniques for measuring fibrosis in patients with head and neck cancer postradiotherapy: A systematic review. Head & neck 38,Suppl 1:E2322-34.

Sun, Y., Yu, X., Zhang, G., et al. (2016). Reduction of clinical target volume in patients with lateralized cancer of the nasopharynx and without contralateral lymph node metastasis receiving intensity-modulated radiotherapy. Head & neck 38,Suppl 1:E468-72.

Sychev, Y.V., McInnis, C.P. and Francis, C.E. (2016). Abducens ocular neuromyotonia as a delayed complication of oropharyngeal carcinoma treated with radiation. Head & neck 38,Suppl 1:E2428-31.

Takiar, V., Ma, D., Garden, A.S., et al. (2016). Disease control and toxicity outcomes for T4 carcinoma of the nasopharynx treated with intensity-modulated radiotherapy. Head & neck 38,Suppl 1:E925-33.

Head and Neck Cancer, May 2016Kirsty Coltart, Subject Librarian, NHSGGC Library Network

6

Thomson, D.J., Beasley, W.J., Garcez, K., et al. (2016). Relative plan robustness of step-and-shoot vs rotational intensity-modulated radiotherapy on repeat computed tomographic simulation for weight loss in head and neck cancer. Medical Dosimetry 41,2:154-158.

Villaflor, V.M., Melotek, J.M., Karrison, T.G., et al. (2016). Response-adapted volume de-escalation (RAVD) in locally advanced head and neck cancer. Annals of Oncology 27,5:908-913.

Vlashi, E., Chen, A.M., Boyrie, S., et al. (2016). Radiation-Induced Dedifferentiation of Head and Neck Cancer Cells Into Cancer Stem Cells Depends on Human Papillomavirus Status. International journal of radiation oncology, biology, physics 94,5:1198-1206.

Wang, L., Chen, Y., Ho, C., et al. (2016). Fractionated Boron Neutron Capture Therapy in Locally Recurrent Head and Neck Cancer: A Prospective Phase I/II Trial. International journal of radiation oncology, biology, physics 95,1:396-403.

Wong, K., Delaney, G.P. and Barton, M.B. (2016). Evidence-based optimal number of radiotherapy fractions for cancer: A useful tool to estimate radiotherapy demand. Radiotherapy & Oncology 119,1:145-149.

Supportive Care & Symptom Management

Alt-Epping, B., Seidel, W., Vogt, J., et al. (2016). Symptoms and Needs of Head and Neck Cancer Patients at Diagnosis of Incurability - Prevalences, Clinical Implications, and Feasibility of a Prospective Longitudinal Multicenter Cohort Study. Oncology Research and Treatment 39,4:186-191.

Balfe, M., O'Brien, K., Timmons, A., et al. (2016). What factors are associated with posttraumatic growth in head and neck cancer carers?. European Journal of Oncology Nursing 21,31-37.

Barber, B., Dergousoff, J., Slater, L., et al. (2016). Depression and Survival in Patients With Head and Neck Cancer: A Systematic Review. JAMA Otolaryngology-- Head & Neck Surgery 142,3:284-288.

Bressan, V., Stevanin, S., Bianchi, M., et al. (2016). The effects of swallowing disorders, dysgeusia, oral mucositis and xerostomia on nutritional status, oral intake and weight loss in head and neck cancer patients: A systematic review. Cancer treatment reviews 45,105-119.

Brown, T.E., Getliffe, V., Banks, M.D., et al. (2016). Validation of an updated evidence-based protocol for proactive gastrostomy tube insertion in patients with head and neck cancer. European journal of clinical nutrition 70,5:574-581.

Buglione, M., Cavagnini, R., Di Rosario, F., et al. (2016). Oral toxicity management in head and neck cancer patients treated with chemotherapy and radiation: Xerostomia and trismus (Part 2). Literature review and consensus statement. Critical Reviews in Oncology-Hematology 102,47-54.

Capozzi, L.C., McNeely, M.L., Lau, H.Y., et al. (2016). Patient-reported outcomes, body composition, and nutrition status in patients with head and neck cancer: Results from an exploratory randomized controlled exercise trial. Cancer 122,8:1185-1200.

Capozzi, L.C., Nishimura, K.C., McNeely, M.L., et al. (2016). The impact of physical activity on health-related fitness and quality of life for patients with head and neck cancer: a systematic review. British journal of sports medicine 50,6:325-338.

Head and Neck Cancer, May 2016Kirsty Coltart, Subject Librarian, NHSGGC Library Network

7

Chen, J., Wang, C., Wong, Y., et al. (2016). Osteoradionecrosis of mandible bone in patients with oral cancer-associated factors and treatment outcomes. Head & neck 38,5:762-768.

De Sanctis, V., Bossi, P., Sanguineti, G., et al. (2016). Mucositis in head and neck cancer patients treated with radiotherapy and systemic therapies: Literature review and consensus statements. Critical Reviews in Oncology-Hematology 100,147-166.

Holmes, S. (2016). A service evaluation of cough reflex testing to guide dysphagia management in the postsurgical adult head and neck patient population. Current Opinion in Otolaryngology & Head & Neck Surgery 24,3:191-196.

Jiang, N., Zhang, L., Li, L., et al. (2016). Risk factors for late dysphagia after (chemo)radiotherapy for head and neck cancer: A systematic methodological review. Head & neck 38,5:792-800.

Langmore, S.E., McCulloch, T.M., Krisciunas, G.P., et al. (2016). Efficacy of electrical stimulation and exercise for dysphagia in patients with head and neck cancer: A randomized clinical trial. Head & neck 38,Suppl 1:E1221-31.

Mason, H., DeRubeis, M.B., Burke, N., et al. (2016). Symptom management during and after treatment with concurrent chemoradiotherapy for oropharyngeal cancer: A review of the literature and areas for future research. World Journal of Clinical Oncology 7,2:220-226.

Mortensen, A. and Jarden, M. (2016). Early and late physical and psychosocial effects of primary surgery in patients with oral and oropharyngeal cancers: a systematic review. Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology 121,6:583-594.

Narwani, V., Nalamada, K., Lee, M., et al. (2016). Readability and quality assessment of internet-based patient education materials related to laryngeal cancer. Head & neck 38,4:601-605.

NICE. IPG550: Endoscopic carbon dioxide laser cricopharyngeal myotomy for relief of oropharyngeal dysphagia (March 2016)

Ouyoung, L.M., Swanson, M.S., Villegas, B.C., et al. (2016). ABCLOVE: Voice therapy outcomes for patients with head and neck cancer. Head & neck 38,Suppl 1:E1810-3.

Patterson, J.M., Brady, G.C. and Roe, J.W.G. (2016). Research into the prevention and rehabilitation of dysphagia in head and neck cancer: a UK perspective. Current Opinion in Otolaryngology & Head & Neck Surgery 24,3:208-214.

Petrosyan, V., Ball, D., Harrison, R., et al. (2016). Among Patients Undergoing Ablative Treatment for Oral Cancer, Does the Provision of Oral Rehabilitation Improve the Quality of Life? A Review of the Current Literature. Journal of Oral & Maxillofacial Surgery 74,5:1096.e1-1096.e12.

Rogers, S.N., Cross, B., Talwar, C., et al. (2016). A single-item screening question for fear of recurrence in head and neck cancer. European Archives of Oto-Rhino-Laryngology 273,5:1235-1242.

Sammut, L., Fraser, L.R., Ward, M.J., et al. (2016). Participation in sport and physical activity in head and neck cancer survivors: associations with quality of life. Clinical Otolaryngology 41,3:241-248.

Stegel, P., Kozjek, N.R., Brumen, B.A., et al. (2016). Bioelectrical impedance phase angle as indicator and predictor of cachexia in head and neck cancer patients treated with (chemo)radiotherapy. European journal of clinical nutrition 70,5:602-606.

Head and Neck Cancer, May 2016Kirsty Coltart, Subject Librarian, NHSGGC Library Network

8

Sterba, K.R., Zapka, J., Cranos, C., et al. (2016). Quality of Life in Head and Neck Cancer Patient-Caregiver Dyads: A Systematic Review. Cancer nursing 39,3:238-250.

van den Berg,Manon G A., Kalf, J.G., Hendriks, J.C.M., et al. (2016). Normalcy of food intake in patients with head and neck cancer supported by combined dietary counseling and swallowing therapy: A randomized clinical trial. Head & neck 38,Suppl 1:E198-206.

Xiong, J., Krishnaswamy, G., Raynor, S., et al. (2016). Risk of swallowing-related chest infections in patients with nasopharyngeal carcinoma treated with definitive intensity-modulated radiotherapy. Head & neck 38,Suppl 1:E1660-5.

Zecha, J.A.E.M., Raber-Durlacher, J.E., Nair, R.G., et al. (2016). Low-level laser therapy/photobiomodulation in the management of side effects of chemoradiation therapy in head and neck cancer: part 2: proposed applications and treatment protocols. Supportive Care in Cancer 24,6:2793-2805.

Zecha, J.A.E.M., Raber-Durlacher, J.E., Nair, R.G., et al. (2016). Low level laser therapy/photobiomodulation in the management of side effects of chemoradiation therapy in head and neck cancer: part 1: mechanisms of action, dosimetric, and safety considerations. Supportive Care in Cancer 24,6:2781-2792.

Zhao, S.G., Alexander, N.B., Djuric, Z., et al. (2016). Maintaining physical activity during head and neck cancer treatment: Results of a pilot controlled trial. Head & neck 38,Suppl 1:E1086-96.

Surgery

Baddour, H.M.J., Magliocca, K.R. and Chen, A.Y. (2016). The importance of margins in head and neck cancer. Journal of surgical oncology 113,3:248-255.

Beswick, D.M., Vashi, A., Song, Y., et al. (2016). Consultation via telemedicine and access to operative care for patients with head and neck cancer in a Veterans Health Administration population. Head & neck 38,6:925-929.

Byrd, J.K. and Ferris, R.L. (2016). Is There a Role for Robotic Surgery in the Treatment of Head and Neck Cancer? Current Treatment Options in Oncology 17,6:29.

Chaput, B., Vergez, S., Somda, S., et al. (2016). Comparison of Single and Double Venous Anastomoses in Head and Neck Oncologic Reconstruction Using Free Flaps: A Meta-Analysis. Plastic & Reconstructive Surgery 137,5:1583-1594.

Coyle, M.J., Main, B., Hughes, C., et al. (2016). Enhanced recovery after surgery (ERAS) for head and neck oncology patients. Clinical Otolaryngology 41,2:118-126.

Cracchiolo, J.R. and Shaha, A.R. (2016). Parotidectomy for Parotid Cancer. Otolaryngologic clinics of North America 49,2:415-424.

Deschler, D.G. and Eisele, D.W. (2016). Surgery for Primary Malignant Parotid Neoplasms. Advances in Oto-Rhino-Laryngology 78,83-94.

Eskander, A., Monteiro, E., Irish, J., et al. (2016). Adherence to guideline-recommended process measures for squamous cell carcinoma of the head and neck in Ontario: Impact of surgeon and hospital volume. Head & neck 38,Suppl 1:E1987-92.

Guntinas-Lichius, O., Genther, D.J. and Byrne, P.J. (2016). Facial Reconstruction and Rehabilitation. Advances in Oto-Rhino-Laryngology 78,120-131.

Head and Neck Cancer, May 2016Kirsty Coltart, Subject Librarian, NHSGGC Library Network

9

Illuminati, G., Schneider, F., Minni, A., et al. (2016). Resection of recurrent neck cancer with carotid artery replacement. Journal of Vascular Surgery 63,5:1272-1278.

Lee, C., Ho, H., Su, Y., et al. (2016). Comparison of different comorbidity measures for oral cancer patients with surgical intervention: A longitudinal study from a single cancer center. Auris, Nasus, Larynx 43,3:322-329.

Lewis, C.M., Aloia, T.A., Shi, W., et al. (2016). Development and Feasibility of a Specialty-Specific National Surgical Quality Improvement Program (NSQIP): The Head and Neck-Reconstructive Surgery NSQIP. JAMA Otolaryngology-- Head & Neck Surgery 142,4:321-327.

Lorincz, B.B., Jowett, N. and Knecht, R. (2016). Decision management in transoral robotic surgery: Indications, individual patient selection, and role in the multidisciplinary treatment for head and neck cancer from a European perspective. Head & neck 38,Suppl 1:E2190-6.

Lorincz, B.B., Langwieder, F., Mockelmann, N., et al. (2016). The impact of surgical technique on neck dissection nodal yield: making a difference. European Archives of Oto-Rhino-Laryngology 273,5:1261-1267.

Ng, L.S., Lim, C.M. and Loh, K.S. (2016). Long-term outcomes of nasopharyngectomy using partial maxillectomy approach. Laryngoscope 126,5:1103-1107.

Poh, C.F., Anderson, D.W., Durham, J.S., et al. (2016). Fluorescence Visualization-Guided Surgery for Early-Stage Oral Cancer. JAMA Otolaryngology-- Head & Neck Surgery 142,3:209-216.

Smits, R.W.H., Koljenovic, S., Hardillo, J.A., et al. (2016). Resection margins in oral cancer surgery: Room for improvement. Head & neck 38,Suppl 1:E2197-203.

Solares, C.A., Mason, E. and Panizza, B.J. (2016). Surgical Management of Perineural Spread of Head and Neck Cancers. Journal of Neurological Surgery Part B Skull Base 77,2:140-149.

Vander Poorten, V., Meulemans, J. and Delaere, P. (2016). Midface prosthetic rehabilitation. Current Opinion in Otolaryngology & Head & Neck Surgery 24,2:98-109.

Please note that the journal articles you are accessing are subject to the terms and conditions imposed by the publisher, so there will be a limit on the number of articles an individual may download or print from a single issue of a journal. You can consult your local NHSGGC library with any queries.

If you have any questions regarding this or any other library services please contact Library staff – contact details are at the beginning of the bulletin.

Sources used for this bulletin:

OVID Medline, SIGN, NICE, Healthcare Improvement Scotland

Head and Neck Cancer, May 2016Kirsty Coltart, Subject Librarian, NHSGGC Library Network

1